Evaluation of protein requirements for trained strength athletes.

Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
Journal of Applied Physiology (Impact Factor: 3.43). 12/1992; 73(5):1986-95.
Source: PubMed

ABSTRACT Leucine kinetic and nitrogen balance (NBAL) methods were used to determine the dietary protein requirements of strength athletes (SA) compared with sedentary subjects (S). Individual subjects were randomly assigned to one of three protein intakes: low protein (LP) = 0.86 g, moderate protein (MP) = 1.40 g, or high protein (HP) = 2.40 g for 13 days for each dietary treatment. NBAL was measured and whole body protein synthesis (WBPS) and leucine oxidation were determined from L-[1-13C]leucine turnover. NBAL data were used to determine that the protein intake for zero NBAL for S was 0.69 and for SA was 1.41 A suggested recommended intake for S was 0.89 and for SA was 1.76 For SA, the LP diet did not provide adequate protein and resulted in an accommodated state (decreased WBPS vs. MP and HP), and the MP diet resulted in a state of adaptation [increase in WBPS (vs. LP) and no change in leucine oxidation (vs. LP)]. The HP diet did not result in increased WBPS compared with the MP diet, but leucine oxidation did increase significantly, indicating a nutrient overload. For S the LP diet provided adequate protein, and increasing protein intake did not increase WBPS. On the HP diet leucine oxidation increased for S. These results indicated that the MP and HP diets were nutrient overloads for S. There were no effects of varying protein intake on indexes of lean body mass (creatinine excretion, body density) for either group. In summary, protein requirements for athletes performing strength training are greater than for sedentary individuals and are above current Canadian and US recommended daily protein intake requirements for young healthy males.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Resumen La sarcopenia es la pérdida de masa muscular esque-lética asociada al envejecimiento, y contribuye en gran medida a la discapacidad y la pérdida de independencia del anciano. En su etiopatogenia se incluyen diversos mecanismos tanto intrínsecos del propio músculo como cambios a nivel del sistema nervioso central, además de factores hormonales y de estilo de vida. Diversas hormo-nas y citoquinas afectan la función y la masa muscular. La reducción de testosterona y estrógenos que acompaña la vejez aceleran la pérdida de masa muscular. La hor-mona de crecimiento también se ha implicado en la pér-dida de masa magra corporal. Aunque la sarcopenia no revierte completamente con el ejercicio, la inactividad fí-sica acelera la pérdida de la masa muscular. El diagnós-tico de sarcopenia está dificultado por la falta de dispo-nibilidad de los métodos más fiables para medir la masa muscular Se han ensayado diversas estrategias para su tratamiento: tratamiento sustitutivo con testosterona / otros andrógenos anabolizantes, estrógenos en mujeres, hormona de crecimiento, tratamiento nutricional y ejer-cicio físico. De todas las alternativas terapéuticas, sólo el ejercicio físico de resistencia ha demostrado su eficacia en incrementar la masa muscular esquelética, asociado o no a suplementación nutricional. Abstract Sarcopenia is the loss of skeletal muscle mass that oc-curs with ageing, and is a major contributing factor to di-sability and loss of independence in the elderly. The etio-pathogenesis involves a number of underlying mechanisms including intrinsic changes in the muscle and central nervous system, and hormonal and lifestyle factors. Many hormones and cytokines affect muscle mass and function. Reductions in testosterone and estro-gens that accompany ageing appear to accelerate loss of muscle mass. Growth hormone has been hypothesised to contribute to loss of lean body mass. Although sarcopenia is not completely reversed with exercise, physical inacti-vity leads to accelerated muscle loss. The diagnosis of sar-copenia is difficult because the most reliable methods to measure muscle mass are not easily available. Various treatment strategies have been tested for combating the loss of muscle mass: testosterone replacement and other anabolic androgens for men, estrogen replacement in wo-men, growth hormone replacement, nutritional treat-ment and physical training. Only high resistance exercise training has been effective in increasing muscle mass, with or without nutritional supplementation.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Amino acids contribute between 2–8% of the energy needs during endurance exercise. Endurance exercise training leads to an adaptive reduction in the oxidation of amino acids at the same absolute exercise intensity, however, the capacity to oxidize amino acids goes up due to the increase in the total amount of the rate limiting enzyme, branched chain 2-oxo-acid dehydrogenase. There appears to be a modest increase (range = 12–95%) in protein requirements only for very well trained athletes who are actively training. Although the majority of athletes will have ample dietary protein to meet any increased need, those on a hypoenergetic diet or during extreme periods of physical stress may need dietary manipulation to accommodate the need. Caffeine is a trimethylxanthine derivative that is common in many foods and beverages. The consumption of caffeine (3–7 mg/kg) prior to endurance exercise improves performance for habitual and non-habitual consumers. The ergogenic effect is likely due to a direct effect on muscle contractility and not via an enhancement of fatty acid oxidation. Creatine is important in intra-cellular energy shuttling and in cellular fluid regulation. Creatine monohydrate supplementation (20 g/d X 3–5 days) increases fat-free mass, improves muscle strength during repetitive high intensity contractions and increases fat-free mass accumulation and strength during a period of weight training. Given the increase in weight, there are likely neutral or even performance reducing effects in sports that are influenced by body mass (i.e., running, hill climbing cycling).
    European Journal of Sport Science 06/2005; 5(2):59-72. DOI:10.1080/17461390500137485 · 1.31 Impact Factor
  • Source


Available from
Jun 3, 2014